Showing 121 - 140 results of 159 for search 'Cancer well reprogramming', query time: 0.11s Refine Results
  1. 121
  2. 122

    Exploring the role of ELOVLs family in lung adenocarcinoma based on bioinformatic analysis and experimental validation by Zihan Wang, Wenjing Cui, Long Liang, Jingge Qu, Yuqiang Pei, Danyang Li, Ying Luo, Yue Zhang, Yifan Qiu, Yongchang Sun

    Published 2025-01-01
    “…Abstract Background The role of lipid metabolic reprogramming in the development of various types of cancer has already been established. …”
    Get full text
    Article
  3. 123

    Mutually exclusive teams-like patterns of gene regulation characterize phenotypic heterogeneity along the noradrenergic-mesenchymal axis in neuroblastoma by Manas Sehgal, Sonali Priyadarshini Nayak, Sarthak Sahoo, Jason A Somarelli, Mohit Kumar Jolly

    Published 2024-12-01
    “…We observed that NOR-specific and MES-specific expression patterns are largely mutually exclusive, exhibiting a “teams-like” behavior among the genes involved, reminiscent of our earlier observations in lung cancer and melanoma. This antagonism between NOR and MES phenotypes was also associated with metabolic reprogramming and with immunotherapy targets PD-L1 and GD2 as well as with experimental perturbations driving the NOR-MES and/or MES-NOR transition. …”
    Get full text
    Article
  4. 124
  5. 125
  6. 126
  7. 127
  8. 128
  9. 129
  10. 130
  11. 131
  12. 132
  13. 133
  14. 134

    Epithelial-mesenchymal transition orchestrates tumor microenvironment: current perceptions and challenges by Yuqi Xie, Xuan Wang, Wenquan Wang, Ning Pu, Liang Liu

    Published 2025-04-01
    “…This review discusses the mechanisms by which EMT coordinates TME dynamics, including secretion of soluble factors, direct cell contact, release of exosomes and enzymes, as well as metabolic reprogramming. Recent evidence also indicates that cells undergoing EMT may differentiate into cancer-associated fibroblasts, thereby establishing themselves as functional constituents of the TME. …”
    Get full text
    Article
  15. 135

    Autocrine INSL5 promotes tumor progression and glycolysis via activation of STAT5 signaling by Shi‐Bing Li, Yan‐Yan Liu, Li Yuan, Ming‐Fang Ji, Ao Zhang, Hui‐Yu Li, Lin‐Quan Tang, Shuo‐Gui Fang, Hua Zhang, Shan Xing, Man‐Zhi Li, Qian Zhong, Shao‐Jun Lin, Wan‐Li Liu, Peng Huang, Yi‐Xin Zeng, Yu‐Ming Zheng, Zhi‐Qiang Ling, Jian‐Hua Sui, Mu‐Sheng Zeng

    Published 2020-07-01
    “…In conclusion, INSL5 enhances NPC progression by regulating cancer cell metabolic reprogramming and is a potential diagnostic and prognostic marker as well as a therapeutic target for NPC.…”
    Get full text
    Article
  16. 136

    A high throughput assay for phosphoribosylformylglycinamidine synthase by Nandini Sharma, Yuka Otsuka, Louis Scampavia, Timothy P. Spicer, Jarrod B. French

    Published 2025-03-01
    “…Metabolic reprogramming of purine biosynthesis is a hallmark of cancer metabolism and represents a critical vulnerability. …”
    Get full text
    Article
  17. 137

    Mesothelin-directed protein-drug conjugates for mesothelin-low solid tumor therapy by Ying Wang, Jiayao Yan, Lin Li, Tianran Chen, Jingyi Guo, Lei Lei, Siwen Wu, Lijing Zhu, Xiaotong Chen, Baorui Liu

    Published 2025-08-01
    “…Notably, M7GA-DC demonstrates enhanced tumor control and improved survival benefits in pancreatic cancer models with limited MSLN expression. Combination therapy with PD-1 blockade further promotes long-term immunological memory formation by activation of dendritic cells and reprogramming of the tumor microenvironment. …”
    Get full text
    Article
  18. 138

    Therapeutic potential of tumor-associated neutrophils: dual role and phenotypic plasticity by Yanting Zhou, Guobo Shen, Xikun Zhou, Jing Li

    Published 2025-06-01
    “…The discussion on promising therapy encompasses five key areas: inhibition of the tumor-promoting effect of TANs, enhancement of the antitumor effect of TANs, targeting the interaction between TANs and the TME, reprogramming of TANs, and drug delivery carriers. Finally, we discuss the potential of TANs and their related markers as emerging biomarkers for predicting the prognosis of cancer patients.…”
    Get full text
    Article
  19. 139
  20. 140

    Spatial protein redistribution: wandering but not lost by Faiza Amterat Abu Abayed, Laila Abu Madegam, Ayelet Gilad, Gal Twito, Suad Sheikh Suliman, Suma Biadsy, Aeid Igbaria

    Published 2025-08-01
    “…This dynamic aspect of proteostasis allows proteins to acquire novel functions based on their subcellular localization, enabling the cell to adapt to both physiological and pathological challenges. Such spatial reprogramming is especially pronounced under stress conditions, including those associated with cancer, neurodegenerative diseases and viral infection, where widespread remodeling of the proteome facilitates survival and adaptation. …”
    Get full text
    Article